Parkinsonism: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
No edit summary
Line 1: Line 1:
__NOTOC__
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''


{{Infobox_Disease
| Name          = {{PAGENAME}}
| Image          =
| Caption        =
| DiseasesDB    = 24212
| ICD10          =
| ICD9          =
| ICDO          =
| OMIM          =
| MedlinePlus    = 000759
| eMedicineSubj  =
| eMedicineTopic =
| MeshID        =
}}
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}
Line 21: Line 8:
'''Parkinsonism''' (also known as '''Parkinson's syndrome''', '''atypical Parkinson's''', or '''secondary Parkinson's''') is a neurological [[syndrome]] characterized by [[tremor]], [[hypokinesia]], [[spasticity|rigidity]], and [[balance disorder|postural instability]].<ref name=Aminoff_2005>{{cite book | author = Aminoff MJ, Greenberg DA, Simon RP | title = Clinical Neurology | publisher = Lange: McGraw-Hill Medical | edition = 6th ed. | pages = 241&ndash;5 |year = 2005 | isbn = 0071423605 }}</ref> The underlying causes of parkinsonism are numerous, and diagnosis can be complex.<ref>{{cite journal | author = Tuite PJ, Krawczewski K | title = Parkinsonism: a review-of-systems approach to diagnosis | journal = Seminars in neurology | volume = 27 | issue = 2 | pages = 113-22 | year = 2007 | pmid = 17390256 | doi = 10.1055/s-2007-971174}}</ref> While the [[neurodegenerative]] condition [[Parkinson's disease]] (PD) is the most common cause of parkinsonism, a wide-range of other [[Etiology|etiologies]] can lead to a similar set of symptoms, including some [[toxins]], a few [[metabolic disease]]s, and a handful of non-PD neurological conditions.<ref>{{cite journal | author = Christine CW, Aminoff MJ | title = Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance | journal = Am. J. Med. | volume = 117 | issue = 6 | pages = 412-9 | year = 2004 | pmid = 15380498 | doi = 10.1016/j.amjmed.2004.03.032}}</ref>  Its most common cause is as a side effect of medications, mainly neuroleptic antipsychotics especially the phenothiazines (such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol and zuclopenthixol) and butyrophenones (such as haloperidol (Haldol)), piperazines (such as ziprasidone), and rarely, antidepressants.
'''Parkinsonism''' (also known as '''Parkinson's syndrome''', '''atypical Parkinson's''', or '''secondary Parkinson's''') is a neurological [[syndrome]] characterized by [[tremor]], [[hypokinesia]], [[spasticity|rigidity]], and [[balance disorder|postural instability]].<ref name=Aminoff_2005>{{cite book | author = Aminoff MJ, Greenberg DA, Simon RP | title = Clinical Neurology | publisher = Lange: McGraw-Hill Medical | edition = 6th ed. | pages = 241&ndash;5 |year = 2005 | isbn = 0071423605 }}</ref> The underlying causes of parkinsonism are numerous, and diagnosis can be complex.<ref>{{cite journal | author = Tuite PJ, Krawczewski K | title = Parkinsonism: a review-of-systems approach to diagnosis | journal = Seminars in neurology | volume = 27 | issue = 2 | pages = 113-22 | year = 2007 | pmid = 17390256 | doi = 10.1055/s-2007-971174}}</ref> While the [[neurodegenerative]] condition [[Parkinson's disease]] (PD) is the most common cause of parkinsonism, a wide-range of other [[Etiology|etiologies]] can lead to a similar set of symptoms, including some [[toxins]], a few [[metabolic disease]]s, and a handful of non-PD neurological conditions.<ref>{{cite journal | author = Christine CW, Aminoff MJ | title = Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance | journal = Am. J. Med. | volume = 117 | issue = 6 | pages = 412-9 | year = 2004 | pmid = 15380498 | doi = 10.1016/j.amjmed.2004.03.032}}</ref>  Its most common cause is as a side effect of medications, mainly neuroleptic antipsychotics especially the phenothiazines (such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol and zuclopenthixol) and butyrophenones (such as haloperidol (Haldol)), piperazines (such as ziprasidone), and rarely, antidepressants.


==Etiology==
==Differential Diagnosis==
If PD has been excluded, the [[differential diagnosis]] or list of potential causes for this syndrome includes:
If PD has been excluded, the [[differential diagnosis]] or list of potential causes for this syndrome includes:
* [[AIDS]] can sometimes lead to the symptoms of Parkinson's disease, due to commonly causing dopaminergic dysfunction.<ref>{{cite journal | author = Tse W, Cersosimo MG, Gracies JM, ''et al'' | title = Movement disorders and AIDS: a review | journal = Parkinsonism Relat. Disord. | volume = 10 | issue = 6 | pages = 323-34 | year = 2004 | pmid = 15261874 | doi = 10.1016/j.parkreldis.2004.03.001}}</ref>  
* [[AIDS]] can sometimes lead to the symptoms of Parkinson's disease, due to commonly causing dopaminergic dysfunction.<ref>{{cite journal | author = Tse W, Cersosimo MG, Gracies JM, ''et al'' | title = Movement disorders and AIDS: a review | journal = Parkinsonism Relat. Disord. | volume = 10 | issue = 6 | pages = 323-34 | year = 2004 | pmid = 15261874 | doi = 10.1016/j.parkreldis.2004.03.001}}</ref>  
Line 46: Line 33:
{{WS}}
{{WS}}


[[Category:Primary care]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Geriatrics]]
[[Category:Geriatrics]]
[[Category:Overview complete]]
[[Category:Disease]]
[[Category:Disease]]

Revision as of 04:42, 13 February 2013

For patient information click here

WikiDoc Resources for Parkinsonism

Articles

Most recent articles on Parkinsonism

Most cited articles on Parkinsonism

Review articles on Parkinsonism

Articles on Parkinsonism in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Parkinsonism

Images of Parkinsonism

Photos of Parkinsonism

Podcasts & MP3s on Parkinsonism

Videos on Parkinsonism

Evidence Based Medicine

Cochrane Collaboration on Parkinsonism

Bandolier on Parkinsonism

TRIP on Parkinsonism

Clinical Trials

Ongoing Trials on Parkinsonism at Clinical Trials.gov

Trial results on Parkinsonism

Clinical Trials on Parkinsonism at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Parkinsonism

NICE Guidance on Parkinsonism

NHS PRODIGY Guidance

FDA on Parkinsonism

CDC on Parkinsonism

Books

Books on Parkinsonism

News

Parkinsonism in the news

Be alerted to news on Parkinsonism

News trends on Parkinsonism

Commentary

Blogs on Parkinsonism

Definitions

Definitions of Parkinsonism

Patient Resources / Community

Patient resources on Parkinsonism

Discussion groups on Parkinsonism

Patient Handouts on Parkinsonism

Directions to Hospitals Treating Parkinsonism

Risk calculators and risk factors for Parkinsonism

Healthcare Provider Resources

Symptoms of Parkinsonism

Causes & Risk Factors for Parkinsonism

Diagnostic studies for Parkinsonism

Treatment of Parkinsonism

Continuing Medical Education (CME)

CME Programs on Parkinsonism

International

Parkinsonism en Espanol

Parkinsonism en Francais

Business

Parkinsonism in the Marketplace

Patents on Parkinsonism

Experimental / Informatics

List of terms related to Parkinsonism

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Parkinsonism (also known as Parkinson's syndrome, atypical Parkinson's, or secondary Parkinson's) is a neurological syndrome characterized by tremor, hypokinesia, rigidity, and postural instability.[1] The underlying causes of parkinsonism are numerous, and diagnosis can be complex.[2] While the neurodegenerative condition Parkinson's disease (PD) is the most common cause of parkinsonism, a wide-range of other etiologies can lead to a similar set of symptoms, including some toxins, a few metabolic diseases, and a handful of non-PD neurological conditions.[3] Its most common cause is as a side effect of medications, mainly neuroleptic antipsychotics especially the phenothiazines (such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol and zuclopenthixol) and butyrophenones (such as haloperidol (Haldol)), piperazines (such as ziprasidone), and rarely, antidepressants.

Differential Diagnosis

If PD has been excluded, the differential diagnosis or list of potential causes for this syndrome includes:

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Aminoff MJ, Greenberg DA, Simon RP (2005). Clinical Neurology (6th ed. ed.). Lange: McGraw-Hill Medical. pp. 241&ndash, 5. ISBN 0071423605.
  2. Tuite PJ, Krawczewski K (2007). "Parkinsonism: a review-of-systems approach to diagnosis". Seminars in neurology. 27 (2): 113–22. doi:10.1055/s-2007-971174. PMID 17390256.
  3. Christine CW, Aminoff MJ (2004). "Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance". Am. J. Med. 117 (6): 412–9. doi:10.1016/j.amjmed.2004.03.032. PMID 15380498.
  4. Tse W, Cersosimo MG, Gracies JM; et al. (2004). "Movement disorders and AIDS: a review". Parkinsonism Relat. Disord. 10 (6): 323–34. doi:10.1016/j.parkreldis.2004.03.001. PMID 15261874.
  5. Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D (2006). "Movement disorders and Creutzfeldt-Jakob disease: a review". Parkinsonism Relat. Disord. 12 (2): 65–71. doi:10.1016/j.parkreldis.2005.10.004. PMID 16364674.
  6. Watanabe Y, Himeda T, Araki T (2005). "Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease" (PDF). Med. Sci. Monit. 11 (1): RA17–23. PMID 15614202.
  7. Wenning GK, Geser F (2003). "Multiple system atrophy". Rev. Neurol. (Paris). 159 (5 Pt 2): 3S31–8. PMID 12773886.
  8. Uc EY, Rodnitzky RL (2003). "Childhood dystonia". Seminars in pediatric neurology. 10 (1): 52–61. doi:10.1016/S1071-9091(02)00010-4. PMID 12785748.
  9. 9.0 9.1 9.2 DeLong MR, Juncos JL (2004). Parkinson's Disease and Other Movement Disorders. In: Harrison's Principles of Internal Medicine (16th ed. ed.). McGraw-Hill Professional. pp. p. 2414. ISBN 0-07-140235-7.
  10. Dinis-Oliveira RJ, Remião F, Carmo H; et al. (2006). "Paraquat exposure as an etiological factor of Parkinson's disease". Neurotoxicology. 27 (6): 1110–22. doi:10.1016/j.neuro.2006.05.012. PMID 16815551.
  11. Thanvi B, Lo N, Robinson T (2005). "Vascular Parkinsonism--an important cause of parkinsonism in older people" (PDF). Age and ageing. 34 (2): 114–9. doi:10.1093/ageing/afi025. PMID 15713855.
  12. Członkowska A, Tarnacka B, Möller JC; et al. (2007). "Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients". Neurol. Neurochir. Pol. 41 (1): 1–12. PMID 17330175.

Template:WH Template:WS